Monday, April 30, 10:45 am- 12:15 pm
Convener: Ilan Miller, Adv., Head of Intellectual Property, Dexcel Pharma
Two major legal arenas are in the heart of any drug development, brand or generic. In the first arena, the patent landscape and future potential litigation are considered. In the second arena, the FDA regulatory pathway and the possible regulatory incentives are considered.
The purpose of this session is to discuss recent development in the patent and FDA arenas, and their impact on the pharmaceutical industry.